This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Air Methods Completes Medically Equipped Bell 407GX Helicopter

DENVER, Nov. 12, 2013 (GLOBE NEWSWIRE) -- Air Methods Corporation (Nasdaq:AIRM) today announced that its United Rotorcraft Division completed and delivered the first of four medically-equipped Bell 407GX helicopters to CareFlite, a non-profit 501(c) 3 corporation providing medical transport across North Texas. The other three medically-equipped Bell 407GXs are anticipated to be completed and delivered to CareFlite by the end of the year.

"United Rotorcraft is honored to have earned CareFlite's trust in completing the medical interior for their four new Bell 407GXs," said Mike Slattery, President, United Rotorcraft. "We were able to leverage our unique internal Federal Aviation Administration Organization Designation Authorization status to quickly obtain Supplemental Type Certification approval for the medical interior and avionics suite and complete the work on this first unit in only 90 days."

Each Bell 407GX is equipped with United Rotorcraft's HEMS medical interior, which includes medical mounts for a ventilator, infusion pump, defibrillator, and balloon pump. The avionics suite features the Garmin G1000H flight deck, which includes high-resolution LCD screens, hosting primary flight display, and multi-function display information, as well as an Integrated Avionics System with Helicopter Terrain Avoidance Warning System, Helicopter Synthetic Vision Technology, Traffic Information Systems, and more. United Rotorcraft also modified each of the Bell 407GXs for night vision operations. The paint was custom designed per CareFlite's specifications and applied by United Rotorcraft, with the heart logo being painted in Chrome Allusion color-shifting paint.

Air Methods Corporation ( www.airmethods.com ) is the global leader in air medical transportation. The Air Medical Services Division is the largest provider of air medical transport services in the United States. The United Rotorcraft Division specializes in the design and manufacture of aeromedical and aerospace technology. The Tourism Division is comprised of Sundance Helicopters, Inc., which provides helicopter tours and charter flights, primarily focusing on Grand Canyon tours. Air Methods' fleet of owned, leased or maintained aircraft features over 400 helicopters and fixed wing aircraft.

Forward Looking Statements: Forward-looking statements in this news release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this press release that are "forward-looking statements", including statements regarding anticipated completion and delivery dates, are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in the Company's filings with the SEC. The Company is under no obligation (and expressly disclaims any obligation) to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Please contact Christine Clarke at (303) 792-7579 to be included on the Company's e-mail distribution list.

CONTACT: Tracey Budz
         Director
         Corporate Communications
         (303) 256-4122
         tbudz@airmethods.com

Air Methods Corporation

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs